What is FoundationOne Heme? How accurate are its detection rates and how is it used to detect genomic alterations that can impact diagnosis, therapy and prognosis in hematologic cancers?

What is FoundationOne Heme? How accurate are its detection rates and how is it used to detect genomic alterations that can impact diagnosis, therapy and prognosis in hematologic cancers?

What is FoundationOne Heme? How accurate are its detection rates and how is it being used to detect genomic alterations that can impact diagnosis, therapy selection and prognosis in hematologic cancers?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Lynn Wang, MD, PhD, FCAP

Professor Lynn Wang, MD, PhD, FCAP

Professor, Division of Genomic and Molecular Pathology
Founding Medical Director
Genomic and Molecular Pathology
University of Chicago Medical Center
Chicago, IL, USA